Structural and Mechanistic Insights Into the Artemis Endonuclease and Strategies for Its Inhibition Yuliana Yosaatmadja1,†, Hannah T

Total Page:16

File Type:pdf, Size:1020Kb

Structural and Mechanistic Insights Into the Artemis Endonuclease and Strategies for Its Inhibition Yuliana Yosaatmadja1,†, Hannah T 9310–9326 Nucleic Acids Research, 2021, Vol. 49, No. 16 Published online 13 August 2021 https://doi.org/10.1093/nar/gkab693 Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition Yuliana Yosaatmadja1,†, Hannah T. Baddock2,†, Joseph A. Newman1, Marcin Bielinski3, Angeline E. Gavard1, Shubhashish M.M. Mukhopadhyay1, Adam A. Dannerfjord1, Christopher J. Schofield3, Peter J. McHugh 2,* and Opher Gileadi 1,* 1Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK, 2Department 3 of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK and The Downloaded from https://academic.oup.com/nar/article/49/16/9310/6350767 by guest on 29 September 2021 Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK Received December 22, 2020; Revised July 20, 2021; Editorial Decision July 25, 2021; Accepted August 11, 2021 ABSTRACT INTRODUCTION Artemis (SNM1C/DCLRE1C) is an endonuclease that Nucleases catalyse the hydrolysis of the phosphodiester plays a key role in development of B- and T- bonds in nucleic acids and are broadly classified as lymphocytes and in dsDNA break repair by non- exonucleases or endonucleases. Exonucleases are often homologous end-joining (NHEJ). Artemis is phos- non sequence-specific, while endonucleases can be fur- phorylated by DNA-PKcs and acts to open DNA hair- ther grouped into sequence-specific endonucleases, such as restriction enzymes, and structure-selective endonucleases pin intermediates generated during V(D)J and class- (1). Artemis (SNM1C or DCLRE1C), along with SNM1A switch recombination. Artemis deficiency leads to (DCLRE1A) and SNM1B (Apollo or DCLRE1B), are hu- congenital radiosensitive severe acquired immune man nucleases that are members of the extended structural deficiency (RS-SCID). Artemis belongs to a super- family of metallo-␤-lactamase (MBL) fold enzymes (2,3). family of nucleases containing metallo-␤-lactamase The N-terminal region of Artemis has a core MBL fold (MBL) and ␤-CASP (CPSF-Artemis-SNM1-Pso2) do- (aa 1–170, 319–361) with an inserted ␤-CASP (CPSF73, mains. We present crystal structures of the catalytic Artemis, SNM1 and PSO2) domain (aa 170–318) (4). ␤- domain of wildtype and variant forms of Artemis, in- CASP domains are present within the larger family of eu- cluding one causing RS-SCID Omenn syndrome. The karyotic nucleic acid processing MBLs and confer both / catalytic domain of the Artemis has similar endonu- DNA RNA binding and nuclease activity (2,5). The C- clease activity to the phosphorylated full-length pro- terminal region of Artemis (aa 362–692) mediates protein- protein interactions, contains post translational modifica- tein. Our structures help explain the predominantly tion (PTM) sites, directs subcellular localization, and may endonucleolytic activity of Artemis, which contrasts modulate catalysis (6–9). with the predominantly exonuclease activity of the Although SNM1A, SNM1B and Artemis have similar closely related SNM1A and SNM1B MBL fold nucle- structures of their core catalytic domains, each has distinct ases. The structures reveal a second metal binding functions and selectivities. While SNM1A and SNM1B are site in its ␤-CASP domain unique to Artemis, which exclusively 5 to 3 exonucleases, Artemis is an endonucle- is amenable to inhibition by compounds including ase (7,9), although a minor 5 to 3 exonuclease activity ebselen. By combining our structural data with that has been reported (10). Human SNM1A localizes to sites from a recently reported Artemis structure, we were of DNA damage, can digest past DNA damage lesions in able model the interaction of Artemis with DNA sub- vitro, and is involved in inter-strand crosslink (ICL) repair strates. The structures, including one of Artemis with (11–13). SNM1B is a shelterin-associated protein required for resection at newly-replicated leading-strand telomeres the cephalosporin ceftriaxone, will help enable the to generate the 3 -overhang necessary for telomere loop (t- rational development of selective SNM1 nuclease in- loop) formation and telomere protection (14–16). SNM1A hibitors. and SNM1B prefer ssDNA substrates in vitro, with an abso- lute requirement for a free 5-phosphate (3,17). By contrast, *To whom correspondence should be addressed. Tel: +44 7880553524; Email: [email protected] Correspondence may also be addressed to Peter J. McHugh. Email: [email protected] †The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors. C The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Research, 2021, Vol. 49, No. 16 9311 Artemis preferentially cleaves hairpins and DNA junctions, cloning (LIC) (38)) into the baculovirus expression vector although it is able to process ssDNA substrates (18–20). pBF-6HZB (GenBank™ accession number KP233213.1), The key roles of Artemis and related DSB repair en- which combines an N-terminal His6 sequence,the Z-basic zymes in both programmed V(D)J recombination and non- tag and a TEV protease cleavage site for efficient purifica- programmed c-NHEJ DSB repair, make them attractive tion. Site-directed mutagenesis was carried out using an in- targets for treatment of cancer, either on their own or in verse PCR method whereby an entire plasmid is amplified combination with chemo- or radiotherapy. The Artemis using complementary mutagenic primers (oligonucleotides) endonuclease activity is responsible for hairpin opening with minimal cloning steps (39), using the Herculase II Fu- in variable (diversity) joining (V(D)J) recombination (21) sion DNA Polymerase (Agilent) for amplification and the and contributes to end-processing in the canonical non- KLD enzyme mix (NEB). homologous end joining (c-NHEJ) DNA repair path- way (22–25). V(D)J recombination is initiated by recog- nition and binding of recombination-activating gene pro- Expression and purification of WT and mutant Artemis with Downloaded from https://academic.oup.com/nar/article/49/16/9310/6350767 by guest on 29 September 2021 teins (RAG1 and RAG2) to recombination signal sequences IMAC (aa 1-362) (RSSs) adjacent to the V, D and J gene segments. Upon Baculovirus generation was performed as described (3). Re- binding, the RAG proteins induce double-strand breaks combinant proteins were produced by infecting Sf9 cells at (DSBs) and create a hairpin at the coding ends (26–28). The 2 × 106 cells/ ml with 1.5 ml of P2 virus for WT and 3 ml Ku heterodimer recognizes the DNA double-strand break of P2 virus for mutants respectively. Infected Sf9 cells were and recruits DNA-dependent protein kinase catalytic sub- harvested 70 h after infection by centrifugation (900 × g, unit (DNA-PKcs) and Artemis to mediate hairpin open- 20 min). The cell pellets were resuspended in 30 ml/lly- ing (19). Following hairpin opening, the NHEJ machin- sis buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 10 ery containing the XRCC4/XLF(PAXX)/DNA-Ligase IV mM imidazole, 5% (v/v) glycerol and 1 mM TCEP), snap complex is recruited to catalyse the processing and ligation frozen in liquid nitrogen, then stored at −80◦C for later reactions at the DNA ends (22,29,30). V(D)J recombination use. is an essential process in antibody maturation (18,31,32). Thawed cell aliquots were lysed by sonication. The lysates Mutations in the Artemis gene cause aberrant hairpin were centrifuged (40 000 × g, 30 min); the supernatant was opening, resulting in severe combined immune deficiency passed through a 0.80 ␮m filter (Millipore), then loaded (RS-SCID), with sensitivity to ionizing radiation due to im- onto an immobilized metal affinity chromatography col- pairment of the predominant DSB repair pathway in mam- umn (IMAC) (Ni-NTA Superflow Cartridge, Qiagen) equi- malian cells, NHEJ (19,21,29), and another form of SCID librated in lysis buffer. The column was washed with lysis (Omenn syndrome) associated with hypomorphic Artemis buffer, then eluted using a linear gradient to elution buffer mutations (33,34). Artemis loss-of-function mutations of- (50 mM HEPES pH 7.5, 500 mM NaCl, 300 mM imidazole, ten comprise large deletions in the first four exons or non- 5% (v/v) glycerol and 1 mM TCEP). Protein-containing sense founder mutation, as found in Navajo and Apache fractions were pooled and passed through an ion exchange Native Americans (35). In addition, missense mutations and column (HiTrap® SP FF GE Healthcare Life Sciences) pre- in-frame deletions in the highly conserved residues such as equilibrated in the SP buffer A (25 mM HEPES pH 7.5, 300 H35, D165 and H228 can also abolish Artemis’ protein mM NaCl, 5% (v/v) glycerol and 1 mM TCEP). Protein was function (36). eluted using a linear gradient to SP buffer B (SP buffer A We present high-resolution crystal structures of the cat- with 1 M NaCl), and fractions containing the ZB-tagged alytic core of Artemis (aa 1–361) containing both MBL and Artemis were identified by electrophoresis. a ␤-CASP domains. The structures reveal that Artemis pos- Artemis containing fractions were pooled and dialysed sesses a second metal binding site in its ␤-CASP domain, overnight at 4◦C in SP buffer A, supplemented with re- not present in SNM1A and SNM1B, that resembles classi- combinant tobacco etch virus (TEV) protease to cleavage cal Cys2His2 zinc finger motifs. Based on our data andan- the His6-ZB tag. The protein was loaded into an ion ex- other recently reported Artemis structure (37), we present a change column (HiTrap® SP FF GE Healthcare Life Sci- model for Artemis DNA binding.
Recommended publications
  • Anti-TERF2 / Trf2 Antibody (ARG59099)
    Product datasheet [email protected] ARG59099 Package: 50 μg anti-TERF2 / Trf2 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes TERF2 / Trf2 Tested Reactivity Hu, Rat Tested Application IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name TERF2 / Trf2 Antigen Species Human Immunogen Recombinant protein corresponding to A81-K287 of Human TERF2 / Trf2. Conjugation Un-conjugated Alternate Names Telomeric DNA-binding protein; TRF2; TTAGGG repeat-binding factor 2; TRBF2; Telomeric repeat- binding factor 2 Application Instructions Application table Application Dilution IHC-P 0.5 - 1 µg/ml WB 0.1 - 0.5 µg/ml Application Note IHC-P: Antigen Retrieval: By heat mediation. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 60 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer 0.9% NaCl, 0.2% Na2HPO4, 0.05% Sodium azide and 5% BSA. Preservative 0.05% Sodium azide Stabilizer 5% BSA Concentration 0.5 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/3 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol TERF2 Gene Full Name telomeric repeat binding factor 2 Background This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex.
    [Show full text]
  • SNM1A (DCLRE1A) (NM 001271816) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC235137 SNM1A (DCLRE1A) (NM_001271816) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: SNM1A (DCLRE1A) (NM_001271816) Human Tagged ORF Clone Tag: Myc-DDK Symbol: DCLRE1A Synonyms: PSO2; SNM1; SNM1A Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RC235137 representing NM_001271816 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGTTAGAAGACATTTCCGAAGAAGACATTTGGGAATACAAATCTAAAAGAAAACCAAAACGAGTTGATC CAAATAATGGCTCTAAAAATATTCTAAAATCTGTTGAAAAAGCAACAGATGGAAAATACCAGTCAAAACG GAGTAGAAACAGAAAAAGAGCCGCAGAAGCTAAAGAGGTGAAGGACCATGAAGTGCCCCTTGGAAATGCA GGTTGTCAGACTTCTGTTGCTTCTAGTCAGAATTCAAGTTGTGGAGATGGTATTCAGCAGACCCAAGACA AGGAAACTACTCCAGGAAAACTCTGTAGAACTCAAAAAAGCCAACACGTGTCCCCAAAGATACGTCCAGT TTATGATGGATACTGTCCAAATTGCCAGATGCCTTTTTCCTCATTGATAGGGCAGACACCTCGATGGCAT GTTTTTGAATGTTTGGATTCTCCACCACGCTCTGAAACAGAGTGTCCTGATGGTCTTCTGTGTACCTCAA CCATTCCTTTTCATTACAAGAGATACACTCACTTCCTGCTAGCTCAAAGCAGGGCTGGTGATCATCCTTT TAGCAGCCCATCACCTGCGTCAGGTGGCAGTTTCAGTGAGACTAAGTCAGGCGTCCTTTGTAGCCTTGAG GAAAGATGGTCTTCGTATCAGAACCAAACTGATAACTCGGTTTCAAATGATCCCTTATTGATGACACAGT ATTTTAAAAAGTCTCCGTCTCTGACTGAAGCCAGTGAAAAGATTTCTACTCATATCCAAACATCCCAACA AGCTCTACAATTTACAGATTTTGTTGAGAATGACAAACTAGTGGGAGTTGCTTTGCGTCTTGCAAACAAC
    [Show full text]
  • Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
    biomolecules Article Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways Aayushi Srivastava 1,2,3,4 , Abhishek Kumar 1,5,6 , Sara Giangiobbe 1, Elena Bonora 7, Kari Hemminki 1, Asta Försti 1,2,3 and Obul Reddy Bandapalli 1,2,3,* 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany; [email protected] (A.S.); [email protected] (A.K.); [email protected] (S.G.); [email protected] (K.H.); [email protected] (A.F.) 2 Hopp Children’s Cancer Center (KiTZ), D-69120 Heidelberg, Germany 3 Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany 4 Medical Faculty, Heidelberg University, D-69120 Heidelberg, Germany 5 Institute of Bioinformatics, International Technology Park, Bangalore 560066, India 6 Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, India 7 S.Orsola-Malphigi Hospital, Unit of Medical Genetics, 40138 Bologna, Italy; [email protected] * Correspondence: [email protected]; Tel.: +49-6221-42-1709 Received: 29 August 2019; Accepted: 10 October 2019; Published: 13 October 2019 Abstract: Evidence of familial inheritance in non-medullary thyroid cancer (NMTC) has accumulated over the last few decades. However, known variants account for a very small percentage of the genetic burden. Here, we focused on the identification of common pathways and networks enriched in NMTC families to better understand its pathogenesis with the final aim of identifying one novel high/moderate-penetrance germline predisposition variant segregating with the disease in each studied family.
    [Show full text]
  • Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
    Stem Cell Rev and Rep DOI 10.1007/s12015-016-9662-8 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani 1 & Adhikarla Syama2 & Renuka Sivapatham3 & Ying Pei4 & Odity Mukherjee2 & Thomas Fellner1 & Xianmin Zeng3,4 & Mahendra S. Rao5,6 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We have recently described manufacturing of hu- help determine which set of tests will be most useful in mon- man induced pluripotent stem cells (iPSC) master cell banks itoring the cells and establishing criteria for discarding a line. (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Keywords Induced pluripotent stem cells . Embryonic stem Reports, 5(4), 647–659, 2015). In this manuscript, we de- cells . Manufacturing . cGMP . Consent . Markers scribe the detailed characterization of the two iPSC clones generated using this process, including whole genome se- quencing (WGS), microarray, and comparative genomic hy- Introduction bridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibra- Induced pluripotent stem cells (iPSCs) are akin to embryonic tion material and with a reporter subclone and lines made by a stem cells (ESC) [2] in their developmental potential, but dif- similar process from different donors. We believe that iPSCs fer from ESC in the starting cell used and the requirement of a are likely to be used to make multiple clinical products. We set of proteins to induce pluripotency [3]. Although function- further believe that the lines used as input material will be used ally identical, iPSCs may differ from ESC in subtle ways, at different sites and, given their immortal status, will be used including in their epigenetic profile, exposure to the environ- for many years or even decades.
    [Show full text]
  • SUPPLEMENTARY APPENDIX a Homozygous Missense Variant in UBE2T Is Associated with a Mild Fanconi Anemia Phenotype
    SUPPLEMENTARY APPENDIX A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype Laura Schultz-Rogers, 1* Francis P. Lach, 2* Kimberly A. Rickman, 2 Alejandro Ferrer, 1 Abhishek A. Mangaonkar, 3 Tanya L. Schwab, 4 Christo - pher T. Schmitz, 4 Karl J. Clark, 4 Nikita R. Dsouza, 5 Michael T. Zimmermann, 5,6 Mark Litzow, 3 Nicole Jacobi, 7 Eric W. Klee, 1,8 Agata Smogorzewska 2# and Mrinal M. Patnaik 3# 1Center for Individualized Medicine, Mayo Clinic, Rochester, MN; 2Laboratory of Genome Maintenance, The Rockefeller University, New York, NY; 3De - partment of Hematology, Mayo Clinic, Rochester, MN; 4Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN; 5Bioinformatics Re - search and Development Laboratory, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI; 6Clinical and Translational Sciences Institute, Medical College of Wisconsin, Milwaukee, WI; 7Department of Hematology Oncology, Hennepin County Medical Center, Min - neapolis, MN and 8Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA *LS-R and FPL contributed equally as co-first authors. #EWK, AS and MMP contributed equally as co-senior authors. Correspondence: MRINAL PATNAIK - [email protected] AGATA SMOGORZEWSKA - [email protected] doi:10.3324/haematol.2020.259275 Supplemental Information Homozygous missense variant in UBE2T is associated with mild Fanconi anemia phenotype Laura Schultz-Rogers1*, Francis P. Lach2*, Kimberly A. Rickman2, Alejandro Ferrer1,
    [Show full text]
  • Differential Expression Profile Analysis of DNA Damage Repair Genes in CD133+/CD133‑ Colorectal Cancer Cells
    ONCOLOGY LETTERS 14: 2359-2368, 2017 Differential expression profile analysis of DNA damage repair genes in CD133+/CD133‑ colorectal cancer cells YUHONG LU1*, XIN ZHOU2*, QINGLIANG ZENG2, DAISHUN LIU3 and CHANGWU YUE3 1College of Basic Medicine, Zunyi Medical University, Zunyi; 2Deparment of Gastroenterological Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi;3 Zunyi Key Laboratory of Genetic Diagnosis and Targeted Drug Therapy, The First People's Hospital of Zunyi, Zunyi, Guizhou 563003, P.R. China Received July 20, 2015; Accepted January 6, 2017 DOI: 10.3892/ol.2017.6415 Abstract. The present study examined differential expression cells. By contrast, 6 genes were downregulated and none levels of DNA damage repair genes in COLO 205 colorectal were upregulated in the CD133+ cells compared with the cancer cells, with the aim of identifying novel biomarkers for COLO 205 cells. These findings suggest that CD133+ cells the molecular diagnosis and treatment of colorectal cancer. may possess the same DNA repair capacity as COLO 205 COLO 205-derived cell spheres were cultured in serum-free cells. Heterogeneity in the expression profile of DNA damage medium supplemented with cell factors, and CD133+/CD133- repair genes was observed in COLO 205 cells, and COLO cells were subsequently sorted using an indirect CD133 205-derived CD133- cells and CD133+ cells may therefore microbead kit. In vitro differentiation and tumorigenicity assays provide a reference for molecular diagnosis, therapeutic target in BABA/c nude mice were performed to determine whether selection and determination of the treatment and prognosis for the CD133+ cells also possessed stem cell characteristics, in colorectal cancer.
    [Show full text]
  • Persistent Transcription-Blocking DNA Lesions Trigger Somatic Growth Attenuation Associated with Longevity
    ARTICLES Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity George A. Garinis1,2, Lieneke M. Uittenboogaard1, Heike Stachelscheid3,4, Maria Fousteri5, Wilfred van Ijcken6, Timo M. Breit7, Harry van Steeg8, Leon H. F. Mullenders5, Gijsbertus T. J. van der Horst1, Jens C. Brüning4,9, Carien M. Niessen3,9,10, Jan H. J. Hoeijmakers1 and Björn Schumacher1,9,11 The accumulation of stochastic DNA damage throughout an organism’s lifespan is thought to contribute to ageing. Conversely, ageing seems to be phenotypically reproducible and regulated through genetic pathways such as the insulin-like growth factor-1 (IGF-1) and growth hormone (GH) receptors, which are central mediators of the somatic growth axis. Here we report that persistent DNA damage in primary cells from mice elicits changes in global gene expression similar to those occurring in various organs of naturally aged animals. We show that, as in ageing animals, the expression of IGF-1 receptor and GH receptor is attenuated, resulting in cellular resistance to IGF-1. This cell-autonomous attenuation is specifically induced by persistent lesions leading to stalling of RNA polymerase II in proliferating, quiescent and terminally differentiated cells; it is exacerbated and prolonged in cells from progeroid mice and confers resistance to oxidative stress. Our findings suggest that the accumulation of DNA damage in transcribed genes in most if not all tissues contributes to the ageing-associated shift from growth to somatic maintenance that triggers stress resistance and is thought to promote longevity. Ageing represents the progressive functional decline that is exempted levels as a result of pituitary dysfunction (Snell and Ames mice) — have an from evolutionary selection because it largely occurs after reproduc- extended lifespan17–20.
    [Show full text]
  • Anti-TERF2 / Trf2 Antibody (ARG59098)
    Product datasheet [email protected] ARG59098 Package: 100 μl anti-TERF2 / Trf2 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes TERF2 / Trf2 Tested Reactivity Hu, Ms Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name TERF2 / Trf2 Antigen Species Human Immunogen Recombinant protein of Human TERF2 / Trf2. Conjugation Un-conjugated Alternate Names Telomeric DNA-binding protein; TRF2; TTAGGG repeat-binding factor 2; TRBF2; Telomeric repeat- binding factor 2 Application Instructions Application table Application Dilution WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Jurkat Calculated Mw 60 kDa Observed Size 70kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol TERF2 Gene Full Name telomeric repeat binding factor 2 Background This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres.
    [Show full text]
  • A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family
    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2018 A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family Linda Molla Follow this and additional works at: https://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Linda Molla June 2018 © Copyright by Linda Molla 2018 A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY Linda Molla, Ph.D. The Rockefeller University 2018 APOBEC2 is a member of the AID/APOBEC cytidine deaminase family of proteins. Unlike most of AID/APOBEC, however, APOBEC2’s function remains elusive. Previous research has implicated APOBEC2 in diverse organisms and cellular processes such as muscle biology (in Mus musculus), regeneration (in Danio rerio), and development (in Xenopus laevis). APOBEC2 has also been implicated in cancer. However the enzymatic activity, substrate or physiological target(s) of APOBEC2 are unknown. For this thesis, I have combined Next Generation Sequencing (NGS) techniques with state-of-the-art molecular biology to determine the physiological targets of APOBEC2. Using a cell culture muscle differentiation system, and RNA sequencing (RNA-Seq) by polyA capture, I demonstrated that unlike the AID/APOBEC family member APOBEC1, APOBEC2 is not an RNA editor. Using the same system combined with enhanced Reduced Representation Bisulfite Sequencing (eRRBS) analyses I showed that, unlike the AID/APOBEC family member AID, APOBEC2 does not act as a 5-methyl-C deaminase.
    [Show full text]
  • Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’S Membrane
    Retinal Cell Biology Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’s Membrane Ilene K. Sugino,1 Vamsi K. Gullapalli,1 Qian Sun,1 Jianqiu Wang,1 Celia F. Nunes,1 Noounanong Cheewatrakoolpong,1 Adam C. Johnson,1 Benjamin C. Degner,1 Jianyuan Hua,1 Tong Liu,2 Wei Chen,2 Hong Li,2 and Marco A. Zarbin1 PURPOSE. To determine whether resurfacing submacular human most, as cell survival is the worst on submacular Bruch’s Bruch’s membrane with a cell-deposited extracellular matrix membrane in these eyes. (Invest Ophthalmol Vis Sci. 2011;52: (ECM) improves retinal pigment epithelial (RPE) survival. 1345–1358) DOI:10.1167/iovs.10-6112 METHODS. Bovine corneal endothelial (BCE) cells were seeded onto the inner collagenous layer of submacular Bruch’s mem- brane explants of human donor eyes to allow ECM deposition. here is no fully effective therapy for the late complications of age-related macular degeneration (AMD), the leading Control explants from fellow eyes were cultured in medium T cause of blindness in the United States. The prevalence of only. The deposited ECM was exposed by removing BCE. Fetal AMD-associated choroidal new vessels (CNVs) and/or geo- RPE cells were then cultured on these explants for 1, 14, or 21 graphic atrophy (GA) in the U.S. population 40 years and older days. The explants were analyzed quantitatively by light micros- is estimated to be 1.47%, with 1.75 million citizens having copy and scanning electron microscopy. Surviving RPE cells from advanced AMD, approximately 100,000 of whom are African explants cultured for 21 days were harvested to compare bestro- American.1 The prevalence of AMD increases dramatically with phin and RPE65 mRNA expression.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,677,067 B2 Toro Et Al
    USOO9677067B2 (12) United States Patent (10) Patent No.: US 9,677,067 B2 Toro et al. (45) Date of Patent: Jun. 13, 2017 (54) COMPOSITIONS AND METHODS FOR (58) Field of Classification Search SYNTHETIC GENE ASSEMBLY None See application file for complete search history. (71) Applicant: TWIST BIOSCIENCE CORPORATION, San Francisco, CA (US) (56) References Cited (72) Inventors: Esteban Toro, Fremont, CA (US); U.S. PATENT DOCUMENTS Sebastian Treusch, San Francisco, CA 3,549,368 A 12/1970 Robert et al. (US): Siyuan Chen, San Mateo, CA 3,920,714 A 11, 1975 Streck (US); Cheng-Hsien Wu, Burlingame, 4,123,661 A 10, 1978 Wolf et al. 4.415,732 A 11/1983 Caruthers et al. CA (US) 4,613,398 A 9/1986 Chiong et al. (73) Assignee: TWIST BIOSCIENCE 4,726,877 A 2/1988 Fryd et al. CORPORATION, San Francisco, CA (Continued) (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this EP OO90789 A1 10, 1983 patent is extended or adjusted under 35 EP O126621 B1 8, 1990 U.S.C. 154(b) by 0 days. (Continued) (21) Appl. No.: 15/154.879 OTHER PUBLICATIONS (22) Filed: May 13, 2016 Abudayyeh et al., C2c2 is a single-component programmable RNA guided RNA-targeting CRISPR effector. Science, available on line, (65) Prior Publication Data Jun. 13, 2016, at: http://zlab.mit.edu/assets/reprints Abudayyeh US 2016/0264958 A1 Sep. 15, 2016 OO Science 2016.pdf, 17 pages. (Continued) Related U.S. Application Data (63) Continuation of application No. Primary Examiner — Kaijiang Zhang PCT/US2016/016636, filed on Feb.
    [Show full text]
  • A System for Enhancing Genome-Wide Coexpression Dynamics Study
    A system for enhancing genome-wide coexpression dynamics study Ker-Chau Li†‡, Ching-Ti Liu, Wei Sun, Shinsheng Yuan†, and Tianwei Yu Department of Statistics, 8125 Mathematical Sciences Building, University of California, Los Angeles, CA 90095-1554 Edited by Michael S. Waterman, University of Southern California, Los Angeles, CA, and approved August 30, 2004 (received for review April 28, 2004) Statistical similarity analysis has been instrumental in elucidation mRNA level. Yet a third possibility can be described in terms of LA. of the voluminous microarray data. Genes with correlated expres- This more advanced concept of statistical association originates sion profiles tend to be functionally associated. However, the from the need to describe a situation as schematized in Fig. 1 Left, majority of functionally associated genes turn out to be uncorre- wherein two opposing trends between X and Y are displayed. The lated. One conceivable reason is that the expression of a gene can positive and negative correlations cancel each other out, rendering be sensitively dependent on the often-varying cellular state. The the overall correlation insignificant. It would be valuable to learn intrinsic state change has to be plastically accommodated by why and how the change of trend occurs. But for real data, such gene-regulatory mechanisms. To capture such dynamic coexpres- hidden trends are not easy to detect directly from the scatterplot of sion between genes, a concept termed ‘‘liquid association’’ (LA) has X and Y. To alleviate the difficulty, we look for additional variables been introduced recently. LA offers a scoring system to guide a that may be associated with the change of the trend.
    [Show full text]